Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting NCT04588662

A Prospective Natural History Study in Uveal Melanoma

A Prospective Natural History Study in Uveal Melanoma — Active Not Recruiting • Oncology • NCT04588662.

📅 11 Aug 2026 ⏱ 2 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
NCT ID
NCT04588662
Start
2021-05-06
Completion
2027-03
ClinicaliQ Trial Snapshot
  • A Prospective Natural History Study in Uveal Melanoma — Active Not Recruiting • Oncology • NCT04588662.
  • Multicenter registry tracking uveal melanoma patients over time to understand disease progression and support new treatment development.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The overall objective of this proposal is to develop and utilize a multicenter UM registry that will, in a longitudinal fashion, capture prospective data in order to characterize the natural history of UM and provide data that will be used to support the development of novel therapies for this disease. The care of patients with UM requires a multi-disciplinary team of physicians that commonly requires the involvement of both radiation oncology and interventional radiology, and is typically directed by an ophthalmologic oncologist at time of initial diagnosis of primary disease.…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘My cancer spread while I waited months for surgery’: The cost of England’s cancer wait times
Oncology · BBC Health · 10 Sep 2026
England's cancer surgery waiting times have deteriorated despite government initiatives aimed at improving them, with patients experiencing significant delays that may allow…
View brief →
Clinical Brief
Pope pictured for first time since surgery and cancer diagnosis
Oncology · BBC Health · 16 Oct 2026
Pope Francis underwent lung cancer surgery at Gemelli Hospital in Rome; public appearance marks recovery milestone following diagnosis First photographic evidence post-operatively…
View brief →
Clinical Brief
New hope for breast cancer patients as life-extending drug now on NHS in England
Oncology · BBC Health · 16 Sep 2026
Enhertu is now available on the NHS in England, extending median overall survival by approximately seven months in eligible breast cancer patients…
View brief →
Clinical Brief
Wellbeing support demand for cancer patients grows
Oncology · BBC Health · 25 Oct 2026
Key Takeaways for Clinical Practice Cancer patients are reporting increased demand for wellbeing support services, suggesting current provision may not meet patient…
View brief →
Clinical Brief
Andy Burnham urged to set dementia waiting-time target
Oncology · BBC Health · 17 Sep 2026
Key Takeaways for Clinical Practice An 18-week referral-to-treatment target for dementia has been proposed and endorsed by England's former national cancer director,…
View brief →
Clinical Brief
How a rapid new test is helping brain tumour patients
Oncology · BBC Health · 25 Sep 2026
The NHS has introduced a rapid diagnostic test for brain tumours that reduces diagnosis time from up to eight weeks to two…
View brief →